Peptide-induced antiviral protection by cytotoxic T cells - PubMed (original) (raw)
Peptide-induced antiviral protection by cytotoxic T cells
M Schulz et al. Proc Natl Acad Sci U S A. 1991.
Abstract
A specific antiviral cytotoxic immune response in vivo could be induced by the subcutaneous injection of the T-cell epitope of the lymphocytic choriomeningitis virus (LCMV) nucleoprotein as an unmodified free synthetic peptide (Arg-Pro-Gln-Ala-Ser-Gly-Val-Tyr-Met-Gly-Asn-Leu-Thr-Ala-Gln) emulsified in incomplete Freund's adjuvant. This immunization rendered mice into a LCMV-specific protective state as shown by the inhibition of LCMV replication in spleens of such mice. The protection level of these mice correlated with the ability to respond to the peptide challenge by CD8+ virus-specific cytotoxic T cells. This is a direct demonstration that peptide vaccines can be antivirally protective in vivo, thus encouraging further search for appropriate mixtures of stable peptides that may be used as T-cell vaccines.
Similar articles
- Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide.
Aichele P, Hengartner H, Zinkernagel RM, Schulz M. Aichele P, et al. J Exp Med. 1990 May 1;171(5):1815-20. doi: 10.1084/jem.171.5.1815. J Exp Med. 1990. PMID: 1692084 Free PMC article. - In vivo induction of a high-avidity, high-frequency cytotoxic T-lymphocyte response is associated with antiviral protective immunity.
Sedlik C, Dadaglio G, Saron MF, Deriaud E, Rojas M, Casal SI, Leclerc C. Sedlik C, et al. J Virol. 2000 Jul;74(13):5769-75. doi: 10.1128/jvi.74.13.5769-5775.2000. J Virol. 2000. PMID: 10846055 Free PMC article. - Recovery from acute virus infection. Role of cytotoxic T lymphocytes in the elimination of lymphocytic choriomeningitis virus from spleens of mice.
Lehmann-Grube F, Moskophidis D, Löhler J. Lehmann-Grube F, et al. Ann N Y Acad Sci. 1988;532:238-56. doi: 10.1111/j.1749-6632.1988.tb36343.x. Ann N Y Acad Sci. 1988. PMID: 3052209 Review. No abstract available. - Principles of cytotoxic T lymphocyte induction and recognition.
Whitton JL, Zhang J. Whitton JL, et al. Curr Top Microbiol Immunol. 1995;202:247-59. doi: 10.1007/978-3-642-79657-9_16. Curr Top Microbiol Immunol. 1995. PMID: 7587366 Review. No abstract available.
Cited by
- Chimeric Human Papillomavirus-16 Virus-like Particles Presenting P18I10 and T20 Peptides from HIV-1 Envelope Induce HPV16 and HIV-1-Specific Humoral and T Cell-Mediated Immunity in BALB/c Mice.
Chen CW, Saubi N, Kilpeläinen A, Joseph-Munné J. Chen CW, et al. Vaccines (Basel). 2022 Dec 21;11(1):15. doi: 10.3390/vaccines11010015. Vaccines (Basel). 2022. PMID: 36679860 Free PMC article. - Vaccination with a synthetic peptide modulates lymphocytic choriomeningitis virus-mediated immunopathology.
Battegay M, Oehen S, Schulz M, Hengartner H, Zinkernagel RM. Battegay M, et al. J Virol. 1992 Feb;66(2):1199-201. doi: 10.1128/JVI.66.2.1199-1201.1992. J Virol. 1992. PMID: 1370548 Free PMC article. - Identification of cytotoxic T lymphocyte epitopes of human herpesvirus 8.
Micheletti F, Monini P, Fortini C, Rimessi P, Bazzaro M, Andreoni M, Giuliani M, Traniello S, Ensoli B, Gavioli R. Micheletti F, et al. Immunology. 2002 Jul;106(3):395-403. doi: 10.1046/j.1365-2567.2002.01424.x. Immunology. 2002. PMID: 12100728 Free PMC article. - Targeting CD137 enhances vaccine-elicited anti-respiratory syncytial virus CD8+ T cell responses in aged mice.
Lee S, Mittler RS, Moore ML. Lee S, et al. J Immunol. 2014 Jan 1;192(1):293-9. doi: 10.4049/jimmunol.1300453. Epub 2013 Nov 27. J Immunol. 2014. PMID: 24285837 Free PMC article.
References
- Nature. 1977 Aug 18;268(5621):646-8 - PubMed
- Nature. 1990 Aug 16;346(6285):629-33 - PubMed
- Immunol Rev. 1979;44:43-70 - PubMed
- Adv Immunol. 1980;30:275-331 - PubMed
- Nature. 1984 Dec 6-12;312(5994):548-51 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous